Summary

KEY FINDINGS
The China computed tomography (CT) scanners market is set to grow with a CAGR of 5.65% over the forecasting years of 2023 to 2032. The market growth of the nation is propelled by a notable rise in the geriatric population, an increase in healthcare expenditure, as well as technological advancements.
MARKET INSIGHTS
China’s healthcare industry benefits from the strong presence of domestic companies such as Neusoft Medical Systems, Anke High-Tech, Mindray Medical International, United Imaging Healthcare, and Guangzhou MeCan Medical Limited. These companies make substantial contributions to the sector. Moreover, China’s remarkable technological advancements were highlighted via the implementation of 5G technology for diagnosing COVID-19 patients at the prestigious West China Hospital of Sichuan University.
In addition, Chinese researchers in Chengdu have achieved a significant breakthrough by developing a compact intelligent mobile computed tomography (CT) scanner. This state-of-the-art scanner, measuring 135 centimeters in height and weighing just 260 kg, features a self-shielding design, emits minimal radiation, and consumes low energy. These technological achievements underscore China’s commitment to innovation and its noteworthy contributions to the advancement of medical diagnostic capabilities. Hence, these factors are set to drive the China computed tomography (CT) scanners market growth during the forecasted period.
COMPETITIVE INSIGHTS
Some of the eminent firms operating in the market include Shenzhen Anke High-Tech Co, Canon Medical Systems Corp, Samsung Electronics, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
2.6. MAJOR MARKET FINDINGS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING PREVALENCE OF CHRONIC DISEASES
3.1.2. INCREASING AWARENESS ABOUT EARLY DIAGNOSIS
3.1.3. ACCELERATED GROWTH OF HOSPITAL AND HEALTHCARE INFRASTRUCTURE
3.2. KEY RESTRAINTS
3.2.1. LACK OF ADEQUATE REIMBURSEMENT AND STRINGENT REGULATORY FRAMEWORK
3.2.2. DEARTH OF WELL-TRAINED AND SKILLED HEALTHCARE PROFESSIONALS
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. MARKET CONCENTRATION ANALYSIS
5. MARKET BY TYPE
5.1. HIGH-END SLICE
5.2. MID-END SLICE
5.3. LOW-END SLICE
5.4. CONE BEAM
6. MARKET BY APPLICATION
6.1. ONCOLOGY
6.2. NEUROLOGY
6.3. CARDIOVASCULAR
6.4. MUSCULOSKELETAL
6.5. OTHER APPLICATIONS
7. MARKET BY END-USER
7.1. HOSPITALS & CLINICS
7.2. DIAGNOSTIC CENTERS
7.3. OTHER END-USERS
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. ANALOGIC CORPORATION
8.2.2. CANON MEDICAL SYSTEMS CORP
8.2.3. CARESTREAM HEALTH
8.2.4. FUJIFILM HOLDINGS CORPORATION
8.2.5. GE HEALTHCARE
8.2.6. KONING CORPORATION
8.2.7. KONINKLIJKE PHILIPS NV
8.2.8. NEUSOFT MEDICAL SYSTEMS
8.2.9. PLANMECA GROUP
8.2.10. SAMSUNG ELECTRONICS
8.2.11. SHENZHEN ANKE HIGH-TECH CO LTD
8.2.12. SHIMADZU CORPORATION
8.2.13. SIEMENS HEALTHINEERS AG
8.2.14. STRYKER CORPORATION